Human platelets express hemochromatosis protein (HFE) and transferrin receptor 2

European Journal of Haematology

Volumn 70, Issue 4, 2003, Pages 201-206

  Hannuksela, Jokke ^a   Parkkila, Seppo ^a,b   Waheed, Abdul ^c   Britton, Robert S ^c   Fleming, Robert E ^c   Bacon, Bruce R ^c   Sly, William S ^c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c Saint Louis University   (United States)

Author keywords

HFE; Iron; Platelet; Transferrin receptor; Transferrin receptor 2

Indexed keywords

HFE PROTEIN; IRON; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CELL TYPE; GENETIC DISORDER; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTESTINE CELL; ION TRANSPORT; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; WESTERN BLOTTING;

BLOOD PLATELETS; BLOTTING, WESTERN; CELL MEMBRANE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEOSTASIS; HUMANS; IRON; MEMBRANE PROTEINS; ORGAN SPECIFICITY; PROTEIN BINDING; RECEPTORS, TRANSFERRIN;

EID: 0037394711     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00029.x     Document Type: Article

References (34)

1. BACON BR, TAVILL AS. Hemochromatosis and the iron overload syndromes. In: ZAKIM D, BOYER TD, eds. Hepatology: A Textbook of Liver Disease. Philadelphia: W.B. Saunders, 1996:1439-1472.
2. FEDER JN, GNIRKE A, THOMAS W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
3. ZHOU XY, TOMATSU S, FLEMING RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998;95:2492-2497.
4. BAHRAM S, GILFILLAN S, KUHN LC, MORET R, SCHULZE JB, LEBEAU A, SCHUMANN K. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Proc Natl Acad Sci USA 1999;96:13312-13317.
5. LEVY JE, MONTROSS LK, COHEN DE, FLEMING MD, ANDREWS NC. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood 1999;94:9-11.
6. FEDER JN, TSUCHIHASHI Z, IRRINKI A, et al. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 1997;272:14025-14028.
7. WAHEED A, PARKKILA S, ZHOU XY, TOMATSU S, TSUCHIHASHI Z, FEDER JN, SCHATZMAN RC, BRITTON RS, BACON BR, SLY WS. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997;94:12384-12389.
8. PARKKILA S, WAHEED A, BRITTON RS, BACON BR, ZHOU XY, TOMATSU S, FLEMING RE, SLY WS. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997;94:13198-13202.
9. WAHEED A, PARKKILA S, SAARNIO J, FLEMING RE, ZHOU XY, TOMATSU S, BRITTON RS, BACON BR, SLY WS. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci USA 1999;96:1579-1584.
10. PARKKILA S, NIEMELÄ O, BRITTON RS, FLEMING RE, WAHEED A, BACON BR, SLY WS. Molecular aspects of iron absorption and HFE expression. Gastroenterology 2001;121:1489-1496.
11. PIETRANGELO A. Physiology of iron transport and the hemochromatosis gene. Am J Physiol Gastrointest Liver Physiol 2002;282:G403-G414.
12. WAHEED A, GRUBB JH, ZHOU XY, TOMATSU S, FLEMING RE, COSTALDI ME, BRITTON RS, BACON BR, SLY WS. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 2002;99:3117-3122.
13. MONTOSI G, PAGLIA P, GARUTI C, GUZMAN CA, BASTIN JM, COLOMBO MP, PIETRANGELO A. WILD-TYPE HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 2000;96:1125-1129.
14. WEST AP Jr, BENNETT MJ, SELLERS VM, ANDREWS NC, ENNS CA, BJORKMAN PJ. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem 2000;275:38135-38138.
15. FLEMING RE, MIGAS MC, HOLDEN CC, WAHEED A, BRITTON RS, TOMATSU S, BACON BR, SLY WS. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci USA 2000;97:2214-2219.
16. CAMASCHELLA C, ROETTO A, CALI A, De GOBBI M, GAROZZO G, CARELLA M, MAJORANO N, TOTARO A, GASPARINI P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15.
17. 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. Blood 2002;100:1075-1077.
18. BERGER M, BRASS LF. Severe thrombocytopenia in iron deficiency anemia. Am J Hematol 1987;24:425-428.
19. SOFF GA, LEVIN J. Thrombocytopenia associated with repletion of iron in iron-deficiency anemia. Am J Med Sci 1988;295:35-39.
20. KELLAR KL, BRIDGES NB, MONROE MC, BELL BA, CALLAWAY CS, EVATT BL. Maintenance of normal platelet mass in anemic Belgrade rats and their response to iron. Exp Hematol 1990;18:979-984.
21. YANG M, COLLIS CS, KELLY M, DIPLOCK AT, RICE-EVANS C. Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers? Eur J Clin Nutr 1999;53:367-374.
22. PRATICO D, PASIN M, BARRY OP, GHISELLI A, SABATINO G, IULIANO L, FITZGERALD GA, VIOLI F. Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. Circulation 1999;99:3118-3124.
23. LOO M, BEGUIN Y. The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood 1999;93:3286-3293.
24. CALISKAN U, ONER AF, KABAKUS N, KOC H. Diminished platelet aggregation in patients with iron deficiency anemia. Clin Appl Thromb Hemost 1999;5:161-163.
25. KUREKCI AE, ATAY AA, SARICI SU, ZEYBEK C, KOSEOGLU V, OZCAN O. Effect of iron therapy on the whole blood platelet aggregation in infants with iron deficiency anemia. Thromb Res 2000;97:281-285.
26. PARKKILA S, WAHEED A, BRITTON RS, FEDER JN, TSUCHIHASHI Z, SCHATZMAN RC, BACON BR, SLY WS. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA 1997;94:2534-2539.
27. PARKKILA AK, PARKKILA S, JUVONEN T, RAJANIEMI H. Carbonic anhydrase isoenzymes I1 and I are present in the zona glomerulosa cells of the human adrenal gland. Histochemistry 1993;99:37-41.
28. LAEMMLI UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
29. PARMLEY RT, HAJDU I, DENYS FR. Ultrastructural localization of the transferrin receptor and transferrin on marrow cell surfaces. Br J Haematol 1983;54:633-641.
30. JANDROT-PERRUS M, BOUTON MC, LANZA F, GUILLIN MC. Thrombin interaction with platelet membrane glycoprotein Ib. Semin Thromb Hemost 1996;22:151-156.
31. DE HAAS M, von DEM BORNE A. CD42b. In: Protein Reviews On The Web (http://www.ncbi.nlm.nih.gov/PROW/guide/1313792269_g.htm).
32. HANNUKSELA J, SAVOLAINEN ER, KOISTINEN P, PARKKILA S. Prevalence of HFE genotypes, C282Y and H63D, in patients with hematologic disorders. Haematologica 2002;87:131-135.
33. KAWABATA H, YANG R, HIRAMA T, VUONG PT, KAWANO S, GOMBART AF, KOEFFLER HP. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999;274:20826-20832.
34. FLEMING RE, AHMANN JR, MIGAS MC, WAHEED A, KOEFFLER HP, KAWABATA H, BRITTON RS, BACON BR, SLY WS. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci USA 2002;99:10653-10658.